Literature DB >> 22859295

Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ.

Jessica Wojtaszek1, Chul-Jin Lee, Sanjay D'Souza, Brenda Minesinger, Hyungjin Kim, Alan D D'Andrea, Graham C Walker, Pei Zhou.   

Abstract

DNA synthesis across lesions during genomic replication requires concerted actions of specialized DNA polymerases in a potentially mutagenic process known as translesion synthesis. Current models suggest that translesion synthesis in mammalian cells is achieved in two sequential steps, with a Y-family DNA polymerase (κ, η, ι, or Rev1) inserting a nucleotide opposite the lesion and with the heterodimeric B-family polymerase ζ, consisting of the catalytic Rev3 subunit and the accessory Rev7 subunit, replacing the insertion polymerase to carry out primer extension past the lesion. Effective translesion synthesis in vertebrates requires the scaffolding function of the C-terminal domain (CTD) of Rev1 that interacts with the Rev1-interacting region of polymerases κ, η, and ι and with the Rev7 subunit of polymerase ζ. We report the purification and structure determination of a quaternary translesion polymerase complex consisting of the Rev1 CTD, the heterodimeric Pol ζ complex, and the Pol κ Rev1-interacting region. Yeast two-hybrid assays were employed to identify important interface residues of the translesion polymerase complex. The structural elucidation of such a quaternary translesion polymerase complex encompassing both insertion and extension polymerases bridged by the Rev1 CTD provides the first molecular explanation of the essential scaffolding function of Rev1 and highlights the Rev1 CTD as a promising target for developing novel cancer therapeutics to suppress translesion synthesis. Our studies support the notion that vertebrate insertion and extension polymerases could structurally cooperate within a megatranslesion polymerase complex (translesionsome) nucleated by Rev1 to achieve efficient lesion bypass without incurring an additional switching mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859295      PMCID: PMC3460478          DOI: 10.1074/jbc.M112.394841

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Roles of yeast DNA polymerases delta and zeta and of Rev1 in the bypass of abasic sites.

Authors:  L Haracska; I Unk; R E Johnson; E Johansson; P M Burgers; S Prakash; L Prakash
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

2.  Evidence for a second function for Saccharomyces cerevisiae Rev1p.

Authors:  J R Nelson; P E Gibbs; A M Nowicka; D C Hinkle; C W Lawrence
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

3.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

4.  Interaction of hREV1 with three human Y-family DNA polymerases.

Authors:  Eiji Ohashi; Yoshiki Murakumo; Naoko Kanjo; Jun-Ichi Akagi; Chikahide Masutani; Fumio Hanaoka; Haruo Ohmori
Journal:  Genes Cells       Date:  2004-06       Impact factor: 1.891

5.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

6.  Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin.

Authors:  Tsuyoshi Okuda; Xinjian Lin; Julie Trang; Stephen B Howell
Journal:  Mol Pharmacol       Date:  2005-03-09       Impact factor: 4.436

7.  Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7.

Authors:  Y Murakumo; Y Ogura; H Ishii; S Numata; M Ichihara; C M Croce; R Fishel; M Takahashi
Journal:  J Biol Chem       Date:  2001-08-02       Impact factor: 5.157

8.  Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol eta and REVl protein.

Authors:  Agnès Tissier; Patricia Kannouche; Marie-Pierre Reck; Alan R Lehmann; Robert P P Fuchs; Agnès Cordonnier
Journal:  DNA Repair (Amst)       Date:  2004-11-02

9.  Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis.

Authors:  Caixia Guo; Paula L Fischhaber; Margaret J Luk-Paszyc; Yuji Masuda; Jing Zhou; Kenji Kamiya; Caroline Kisker; Errol C Friedberg
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

10.  Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1.

Authors:  Anna-Laura Ross; Laura J Simpson; Julian E Sale
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

View more
  66 in total

1.  The Proliferating Cell Nuclear Antigen (PCNA)-interacting Protein (PIP) Motif of DNA Polymerase η Mediates Its Interaction with the C-terminal Domain of Rev1.

Authors:  Elizabeth M Boehm; Kyle T Powers; Christine M Kondratick; Maria Spies; Jon C D Houtman; M Todd Washington
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

2.  The architecture of yeast DNA polymerase ζ.

Authors:  Yacob Gómez-Llorente; Radhika Malik; Rinku Jain; Jayati Roy Choudhury; Robert E Johnson; Louise Prakash; Satya Prakash; Iban Ubarretxena-Belandia; Aneel K Aggarwal
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

3.  A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.

Authors:  Jessica L Wojtaszek; Nimrat Chatterjee; Javaria Najeeb; Azucena Ramos; Minhee Lee; Ke Bian; Jenny Y Xue; Benjamin A Fenton; Hyeri Park; Deyu Li; Michael T Hemann; Jiyong Hong; Graham C Walker; Pei Zhou
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

Review 4.  Translesion DNA polymerases in eukaryotes: what makes them tick?

Authors:  Alexandra Vaisman; Roger Woodgate
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-03-09       Impact factor: 8.250

Review 5.  Mechanisms of DNA damage, repair, and mutagenesis.

Authors:  Nimrat Chatterjee; Graham C Walker
Journal:  Environ Mol Mutagen       Date:  2017-05-09       Impact factor: 3.216

6.  Rev7 dimerization is important for assembly and function of the Rev1/Polζ translesion synthesis complex.

Authors:  Alessandro A Rizzo; Faye-Marie Vassel; Nimrat Chatterjee; Sanjay D'Souza; Yunfeng Li; Bing Hao; Michael T Hemann; Graham C Walker; Dmitry M Korzhnev
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-15       Impact factor: 11.205

7.  Analyzing the Catalytic Activities and Interactions of Eukaryotic Translesion Synthesis Polymerases.

Authors:  Kyle T Powers; M Todd Washington
Journal:  Methods Enzymol       Date:  2017-05-08       Impact factor: 1.600

8.  Structure and functional analysis of the BRCT domain of translesion synthesis DNA polymerase Rev1.

Authors:  John M Pryor; Lokesh Gakhar; M Todd Washington
Journal:  Biochemistry       Date:  2012-12-20       Impact factor: 3.162

Review 9.  REV1 and DNA polymerase zeta in DNA interstrand crosslink repair.

Authors:  Shilpy Sharma; Christine E Canman
Journal:  Environ Mol Mutagen       Date:  2012-10-13       Impact factor: 3.216

10.  Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction.

Authors:  Marcelo L Actis; Nigus D Ambaye; Benjamin J Evison; Youming Shao; Murugendra Vanarotti; Akira Inoue; Ezelle T McDonald; Sotaro Kikuchi; Richard Heath; Kodai Hara; Hiroshi Hashimoto; Naoaki Fujii
Journal:  Bioorg Med Chem       Date:  2016-07-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.